Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,243,255 | 2,223,000 | 2,833,000 | 2,590,000 | 2,938,000 |
| Marketable Securities | 197,611 | 191,000 | 149,000 | 175,000 | 50,000 |
| Receivables | 4,265,026 | 3,629,000 | 3,352,000 | 3,312,000 | 3,218,000 |
| Inventories | 1,961,923 | 1,647,000 | 1,311,000 | 1,255,000 | 1,478,000 |
| Other current assets | 261,088 | 222,000 | 249,000 | 236,000 | 177,000 |
| TOTAL | $7,928,903 | $7,912,000 | $7,894,000 | $7,568,000 | $7,861,000 |
| Non-Current Assets | |||||
| PPE Net | 2,170,879 | 1,945,000 | 2,154,000 | 2,205,000 | 2,384,000 |
| Investments And Advances | 826,214 | 824,000 | 831,000 | 835,000 | 928,000 |
| Intangibles | 10,156,878 | 12,401,000 | 6,698,000 | 7,594,000 | 8,428,000 |
| Other Non-Current Assets | 958,109 | 558,000 | 892,000 | 915,000 | 883,000 |
| TOTAL | $14,112,080 | $15,728,000 | $10,575,000 | $11,549,000 | $12,623,000 |
| Total Assets | $22,040,990 | $23,640,000 | $18,470,000 | $19,118,000 | $20,483,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,759,118 | 3,128,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,239,744 | 1,226,000 | 1,054,000 | 1,072,000 | 1,124,000 |
| Other current liabilities | 3,646,797 | 3,259,000 | 3,011,000 | 2,782,000 | 2,802,000 |
| TOTAL | $7,006,626 | $8,515,000 | $5,459,000 | $5,635,000 | $5,337,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,728,294 | 2,965,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,283,264 | 1,250,000 | 1,628,000 | 1,467,000 | 2,495,000 |
| TOTAL | $5,046,888 | $4,555,000 | $1,673,000 | $1,515,000 | $2,659,000 |
| Total Liabilities | $12,053,510 | $13,070,000 | $7,132,000 | $7,148,000 | $7,996,000 |
| Shareholders' Equity | |||||
| Common Shares | 679,807 | 682,000 | 774,000 | 844,000 | 928,000 |
| Retained earnings | 4,890,197 | 5,360,000 | 6,828,000 | 7,740,000 | 8,588,000 |
| Other shareholders' equity | 3,442,770 | 3,532,000 | 2,562,000 | 2,029,000 | 1,509,000 |
| TOTAL | $9,987,483 | $10,569,000 | $11,338,000 | $11,970,000 | $12,488,000 |
| Total Liabilities And Equity | $22,040,993 | $23,639,000 | $18,470,000 | $19,118,000 | $20,484,000 |